These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 21566283)
1. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells]. Huang C; Cao P; Xie Z; Zhu H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283 [TBL] [Abstract][Full Text] [Related]
2. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells. Huang C; Li Y; Cao P; Xie Z; Qin Z J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):488. PubMed ID: 21823010 [TBL] [Abstract][Full Text] [Related]
4. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933 [TBL] [Abstract][Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C; Guan X; Xue H; Wang P; Wang M; Gai X Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [TBL] [Abstract][Full Text] [Related]
6. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876 [TBL] [Abstract][Full Text] [Related]
7. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells. Li Y; Sun Y; Tang T; Niu Y; Li X; Xie M; Jin H; Mei Q J Ethnopharmacol; 2019 Mar; 232():47-54. PubMed ID: 30552993 [TBL] [Abstract][Full Text] [Related]
8. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704 [TBL] [Abstract][Full Text] [Related]
9. Combination of 7- Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024 [TBL] [Abstract][Full Text] [Related]
10. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265 [TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
12. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303 [TBL] [Abstract][Full Text] [Related]
13. [Reversal effect and its mechanism of (- )-5-N-acetylardeemin on adriamycin resistance in multidrug-resistant cancer cells A549/Adr and MCF-7/Adr]. Zhao C; Zheng XL; Yan YY; Song H; Li DX; Yang L; Qin Y; Lin Y; Wang X; Liao LC Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):893-7. PubMed ID: 25571710 [TBL] [Abstract][Full Text] [Related]
14. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells. Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231 [TBL] [Abstract][Full Text] [Related]
15. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells. Budworth J; Gant TW; Gescher A Br J Cancer; 1997; 75(9):1330-5. PubMed ID: 9155054 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation. Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858 [TBL] [Abstract][Full Text] [Related]
17. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway. Yang L; Zhang C; Chen J; Zhang S; Pan G; Xin Y; Lin L; You Z Pharm Biol; 2020 Dec; 58(1):276-285. PubMed ID: 32251615 [No Abstract] [Full Text] [Related]
18. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance. Chen G; Waxman DJ J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498 [TBL] [Abstract][Full Text] [Related]
19. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro. Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360 [TBL] [Abstract][Full Text] [Related]
20. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines. Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]